Skip to content

PRESSURE CHECK: Find Your Path to Better Health

PRESSURE CHECK: Find Your Path to Better Health

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06122246
Acronym
PRESSURE CHECK
Enrollment
1440
Registered
2023-11-08
Start date
2024-04-14
Completion date
2027-08-31
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

hypertension, remote patient monitoring, community health worker, digital health

Brief summary

This study seeks to develop the evidence for a sustainable, community-partnered, multi-level health system strategy to improve blood pressure control. Two team-based approaches are being tested: 1) a medical model of remote BP management (RBPM) alone, and 2) RBPM plus a social model with a community health worker (CHW). These 2 strategies are being compared with a standard community screening program with referral to primary care.

Detailed description

In this comparative effectiveness trial, we aim to answer the research question of whether a remote blood pressure management program (RBPM, inclusive of home blood pressure monitoring and telehealth visits with a nurse or pharmacist delivering protocol-supported BP management, inclusive of medications and lifestyle modifications) alone or an RBPM program with community health worker (CHW) support is more effective than standard screening with education and referral to primary care in controlling blood pressure and addressing social determinants that lead to poor health outcomes. This is a multisite study using a stepped wedge design. Health systems in 4 different cities are each partnered with 10 community based organizations (CBOs). CBOs are randomized into one of 4 sequences. Each sequence moves through the 3 study arms at different time points: Community Standard, RBPM alone, and RBPM+CHW. At the CBOs, research health advocates screen for hypertension. Qualifying individuals who provide informed consent can enroll in the study and are assigned to the intervention that the CBO is in at that particular time. All participants receive a blood pressure cuff and a device that syncs their data with the research database. If enrolled in the RBPM arm, participants are scheduled for telehealth visits with the Pressure Check medical team to improve blood pressure control through lifestyle support and medication initiation/titration. If enrolled in the RBPM+CHW arm, participants additionally receive support from a CHW to help with medical visits and address social determinants of health. The primary outcome is blood pressure control at 6 months. Additional outcomes include implementation science to understand factors associated with adoption and outcomes, and 12 and 18 month blood pressure control. In partnering with the community, health systems can extend their reach. CBO leaders support health messaging around hypertension and increase trust between the health system and their clients (patients). The two models, RBPM alone and RBPM+CHW, are based on the concept that disparities in hypertension control among Black, Latinx, and low-income populations exist because of inequities related to health system access and trust, individual-level socioeconomic and lifestyle factors, the physical/built environment, sociocultural factors, and discriminatory policies. Addressing these barriers may improve blood pressure control.

Interventions

Participants will receive the additional support of a Community Health Worker (CHW); specific activities include: support with home BP monitoring, reminders to attend RBPM clinical visits, and support with social issues impacting health (e.g., food insecurity; transportation; housing instability).

OTHERRemote Blood Pressure (BP) Management Program (RBPM)

Participants will receive a medical model of remote BP management (RBPM). Care is guided by protocols based on ACC/AHA High Blood Pressure Guidelines. This may include medications and/or lifestyle modifications, as is clinically indicated and personalized to each participant using principles of shared decision making.

Sponsors

Yale University
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Community Based Organizations (CBO) will be randomized in a cluster-randomized stepped-wedge design in which CBOs will be randomized to one of 5 sequences.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elevated BP, defined as an average resting BP of \>=135/85 mmHg based on 3 consecutive blood pressure readings

Exclusion criteria

* People who are pregnant or who plan to become pregnant in the next 6 months at study entry * Those that have end stage renal disease on dialysis * People receiving active chemotherapy

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure Control6 monthsParticipants will be assessed at 6 months for Blood Pressure (BP) control- defined as BP \<130/80 mmHg. To assess BP control, blood pressure will be measured in-person at the CBO (or another location) at Baseline, 6, 12 and 18 months with the primary endpoint of assessment as BP control at 6 months.

Secondary

MeasureTime frameDescription
Difference in systolic BP between study groups, measured at CBO6 months, 12 months, 18 monthsMean difference in BP measured at CBO at baseline and follow-up; take average of last 2 of 3 measurements
Difference in BP control by study group, measured at CBO6 months, 12 months, 18 monthsProportion of participants with BP with: Ideal \<120/80 mmHg Intermediate: \<=135/85 mmHg Poor: \>135/85mmHg
Change in Well-being6 months, 12 months, 18 monthsWell-being is assessed with the 12-item 100 Million Healthier Lives. Cantrill's Ladder: stratification into Thriving, Suffering, Struggling. Will assess mean differences of 0.5 as meaningfully different
Change in Lifestyle behaviors6 months, 12 months, 18 monthsDifferences in self-reported measures using a survey.Each measure is categorized as "ideal"(2 points), "intermediate"(1 point) or "poor" (0 point).

Countries

United States

Contacts

CONTACTBonnie Garmisa, MAT
bonnie.garmisa@yale.edu(203) 640-2684
CONTACTJocelyn Dorney, MPH
Jocelyn.dorney@yale.edu708-663-0053
PRINCIPAL_INVESTIGATORErica Spatz, MD

Yale University

PRINCIPAL_INVESTIGATORRafael Perez-Escamilla, MD

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026